Table 4 |
||||
|
Estimates of titers of neutralizing antibodies required for sterile protection against HIV. |
||||
|
Investigator |
Titer |
SN End Point |
Species |
Remarks |
|
|
||||
|
Trkola et al [58] |
1/200 |
70% |
Human |
Acute infection |
|
Parren et al [60] |
1/400 |
90% |
Macaques |
SHIV Challenge |
|
Nishimura et al. [61] |
1/38 |
100% |
Macaques |
SHIV Challenge |
|
1/50, 1/29–1/88 |
90% |
Macaques |
SHIV Challenge |
|
|
Trkola et al [59] |
1/400 |
90% |
Human |
Rebound after HAART |
|
|
||||
|
Plotkin Journal of the International AIDS Society 2009 12:2 doi:10.1186/1758-2652-12-2 |
||||
